European Consumers Use of Internet for Pharmaceutical Information

Manhattan ResearchIn today's world of fragmented media and channel mix, it is increasingly difficult to isolate the information sources used by consumers to research health information and inform healthcare decision making. This is especially the case across Europe, where consumers are accessing an expanding range of resources which vary greatly by country and by region.

Enter Cybercitizen® Health Europe, a new research study and advisory service offered by Manhattan Research. This study provides pharmaceutical and healthcare companies with key data about the evolving nature of consumer channel mix, media and technology usage, and healthcare information with the goal of helping companies understand how consumers across Europe access health information, and how they use that information to make critical healthcare decisions for themselves and their families.

In addition to defining broad online health technology trends, Cybercitizen® Health Europe will investigate topics such as Internet usage, search engine usage, local European versus global websites, product websites, health portals, health information seeking methods, email communication, patient-physician interactions, unbranded patient education, health e-commerce and more. Furthermore, the study will reveal leading health and pharma websites based on the number of visiting European consumers, while detailing consumer satisfaction with site content and features.

Webinar Presentation
A free, private webinar is offered to qualified business accounts to review additional information about Cybercitizen® Health Europe as well as charter sponsorship details. Please visit www.manhattanresearch.com/ccheu.aspx to register for the webinar or to request additional information.

The Cybercitizen® Health Europe syndicated multi-client study and advisory service will be fielded as an online panel study among 3,300 European consumers in total from the United Kingdom, Germany, Spain, Italy, France, Belgium, Sweden, the Netherlands, Poland, and Portugal. The study will explore these topics and many more:

  • Overall media consumption
  • Frequency and types of Internet access
  • Technology adoption like MP3/iPod, PDA, SMS messaging, Smartphones
  • Advanced activities online like online video, blogs, podcasting, wikis
  • Use and relative influence of physicians, nurses, pharmacists, friends and family
  • Search engine reliance and behaviour
  • Use and interest in health email newsletters, support groups, chat rooms, and disease management tools
  • Interest in Web 2.0 technologies for health and pharmaceutical information

About Manhattan Research Products and Service
In addition to Cybercitizen® Health Europe, Manhattan Research conducts five annual research studies among consumers and physicians in the United States and in Europe. These studies include Cybercitizen® Health US, Taking the Pulse® Europe, Taking the Pulse® US, ePharma Physician®, and ePharma Consumer®. Each study serves a unique purpose and focuses on specific aspects of information technology adoption. Broad consumer and physician research is complemented by targeted analysis among more than 50 consumer therapeutic segments and 25 physician specialist segments. For further information, please visit www.manhattanresearch.com

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...